Prelude Therapeutics Inc
PRLD0.851USD
+0.022+2.72%
시장 운영 시간 （ET）시세는 15분 지연됩니다
USD0.000장전 거래 (ET)
48.03M시가총액
손실P/E TTM
분기별
분기별+연간
분기별
연간
YOY
빈 행 숨기기
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2019Q4
FY2019Q3
총 수익
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
수익
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
영업 비용
0.77%34.61M
1.21%37.83M
11.95%37.38M
14.71%37.16M
17.96%34.34M
11.96%37.38M
9.80%33.38M
9.97%32.40M
-3.87%29.11M
1.14%33.38M
-1.39%30.41M
5.51%29.46M
37.88%30.29M
69.75%33.01M
69.95%30.84M
--27.92M
--21.97M
92.63%19.45M
163.57%18.14M
--10.10M
--6.88M
연구개발비
5.13%28.82M
4.25%31.62M
12.17%29.46M
18.20%29.51M
25.53%27.41M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
2.74%25.87M
0.74%22.89M
-4.90%21.31M
38.56%22.82M
72.78%25.18M
48.57%22.72M
--22.41M
--16.47M
64.67%14.57M
178.56%15.29M
--8.85M
--5.49M
감가상각 및 고갈비용
2.11%435.00K
47.73%489.00K
45.16%405.00K
60.85%452.00K
53.24%426.00K
-8.56%331.00K
-17.21%279.00K
-11.64%281.00K
-9.45%278.00K
24.83%362.00K
26.69%337.00K
59.80%318.00K
91.88%307.00K
118.05%290.00K
87.32%266.00K
--199.00K
--160.00K
3.91%133.00K
43.43%142.00K
--128.00K
--99.00K
영업 이익
-0.77%-34.61M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-11.96%-37.38M
-9.80%-33.38M
-9.97%-32.40M
3.87%-29.11M
-1.14%-33.38M
1.39%-30.41M
-5.51%-29.46M
-37.88%-30.29M
-69.75%-33.01M
-69.95%-30.84M
---27.92M
---21.97M
-92.63%-19.45M
-163.57%-18.14M
---10.10M
---6.88M
영업외 순이자수익(비용)
기타 영업외 수익(비용)
-13.43%2.52M
18.49%5.10M
-24.20%2.10M
23.23%2.42M
108.45%2.91M
-9.27%4.30M
519.87%2.78M
-5.75%1.97M
69.74%1.40M
2723.81%4.74M
200.67%448.00K
97.45%2.09M
23.39%823.00K
-14.29%168.00K
-89.23%149.00K
--1.06M
--667.00K
250.00%196.00K
822.67%1.38M
--56.00K
--150.00K
세전 소득
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
세후 소득
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
계속 영업 순이익
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
지배지분 귀속 순이익
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
보통주주 귀속 순이익
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
기본 주당순이익
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
28.33%-0.45
6.55%-0.54
7.25%-0.58
17.33%-0.60
4.68%-0.63
0.73%-0.58
-35.37%-0.63
-40.02%-0.73
83.12%-0.66
---0.58
---0.46
77.93%-0.52
-148.89%-3.92
---2.35
---1.58
희석 주당순이익
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
28.33%-0.45
6.55%-0.54
7.25%-0.58
17.33%-0.60
4.68%-0.63
0.73%-0.58
-35.37%-0.63
-40.02%-0.73
83.12%-0.66
---0.58
---0.46
77.93%-0.52
-148.89%-3.92
---2.35
---1.58
주당 배당금
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
통화 단위
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
감사 의견
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
